NEW YORK, Sept. 24, 2012 \/PRNewswire\/ --Reportlinker.com announces that a new market research report is available in its catalogue: <\/p>\n
Competitive Handbook towards Personalized Medicine in Prostate Cancer <\/p>\n
http:\/\/www.reportlinker.com\/p0980851\/Competitive-Handbook-towards-Personalized-Medicine-in-Prostate-Cancer.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication<\/a> <\/p>\n Personalized medicine is very much about fitting target profiles of drugs towards disease mechanism(s). This report is a new and unique way of stratifying and analyzing the global prostate cancer pipeline towards personalized medicine and presents actionable analysis which allows you to discover: <\/p>\n * Where the competition is; Which targets, compound types and companies are setting the path? <\/p>\n * How much R&D effort has gone towards different targets and what is known about the target? <\/p>\n * Which pathways are targeted, by what and how? <\/p>\n * What is truly new and unique in the prostate cancer pipeline? <\/p>\n * How new and unique your target strategy really is <\/p>\n * What overlapping competition you have from other companies and compound types towards your therapeutic targets <\/p>\n<\/p>\n View original post here:<\/p>\n Competitive Handbook towards Personalized Medicine in Prostate Cancer<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" NEW YORK, Sept. 24, 2012 \/PRNewswire\/ --Reportlinker.com announces that a new market research report is available in its catalogue: Competitive Handbook towards Personalized Medicine in Prostate Cancer http:\/\/www.reportlinker.com\/p0980851\/Competitive-Handbook-towards-Personalized-Medicine-in-Prostate-Cancer.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication<\/a> Personalized medicine is very much about fitting target profiles of drugs towards disease mechanism(s) Continue reading